Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narasimhan Nagan

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Protocols in Human Genetics|January 3, 2016
Spinal Muscular Atrophy: Overview of Molecular Diagnostic ApproachesThomas W Prior, Narasimhan Nagan
American Journal of Medical Genetics. Part A|June 27, 2007
Ovarian failure in ataxia with oculomotor apraxia type 2David R Lynch, Corey D Braastad, Narasimhan Nagan
The Journal of Molecular Diagnostics : JMD|January 14, 2011
Laboratory guidelines for detection, interpretation, and reporting of maternal cell contamination in prenatal analyses a report of the association for molecular pathologyNarasimhan Nagan, Nicole E Faulkner, Christine Curtis, et al.
Alzheimer Disease and Associated Disorders|September 7, 2007
Fragile X premutation in a woman with cognitive impairment, tremor, and history of premature ovarian failureJomana T Al-Hinti, Narasimhan Nagan, Sami I Harik
American Journal of Medical Genetics. Part A|April 19, 2006
A novel duplication/insertion mutation of NEFL in a patient with Charcot-Marie-Tooth diseaseConrad L Leung, Narasimhan Nagan, Thomas H Graham, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 16, 2011
Technical standards and guidelines for spinal muscular atrophy testingThomas W Prior, Narasimhan Nagan, Elaine A Sugarman, et al.
The Journal of Molecular Diagnostics : JMD|January 14, 2011
Population carrier screening for spinal muscular atrophy a position statement of the association for molecular pathologyKasinathan Muralidharan, Robert B Wilson, Shuji Ogino, et al.
Journal of Lipid Research|February 3, 2005
Role of dihydroxyacetonephosphate acyltransferase in the biosynthesis of plasmalogens and nonether glycerolipidsDailan Liu, Narasimhan Nagan, Wilhelm W Just, et al.
Molecular Genetics and Metabolism|April 23, 2003
The frequency of short-chain acyl-CoA dehydrogenase gene variants in the US population and correlation with the C(4)-acylcarnitine concentration in newborn blood spotsNarasimhan Nagan, Kent E Kruckeberg, Angela L Tauscher, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Distinct rates of VUS reclassification are observed when subclassifying VUS by evidence levelGwendolyn Bennett, Izabela Karbassi, Wenjie Chen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Protocols in Human Genetics|January 3, 2016
Spinal Muscular Atrophy: Overview of Molecular Diagnostic ApproachesThomas W Prior, Narasimhan Nagan
American Journal of Medical Genetics. Part A|June 27, 2007
Ovarian failure in ataxia with oculomotor apraxia type 2David R Lynch, Corey D Braastad, Narasimhan Nagan
The Journal of Molecular Diagnostics : JMD|January 14, 2011
Laboratory guidelines for detection, interpretation, and reporting of maternal cell contamination in prenatal analyses a report of the association for molecular pathologyNarasimhan Nagan, Nicole E Faulkner, Christine Curtis, et al.
Alzheimer Disease and Associated Disorders|September 7, 2007
Fragile X premutation in a woman with cognitive impairment, tremor, and history of premature ovarian failureJomana T Al-Hinti, Narasimhan Nagan, Sami I Harik
American Journal of Medical Genetics. Part A|April 19, 2006
A novel duplication/insertion mutation of NEFL in a patient with Charcot-Marie-Tooth diseaseConrad L Leung, Narasimhan Nagan, Thomas H Graham, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 16, 2011
Technical standards and guidelines for spinal muscular atrophy testingThomas W Prior, Narasimhan Nagan, Elaine A Sugarman, et al.
The Journal of Molecular Diagnostics : JMD|January 14, 2011
Population carrier screening for spinal muscular atrophy a position statement of the association for molecular pathologyKasinathan Muralidharan, Robert B Wilson, Shuji Ogino, et al.
Journal of Lipid Research|February 3, 2005
Role of dihydroxyacetonephosphate acyltransferase in the biosynthesis of plasmalogens and nonether glycerolipidsDailan Liu, Narasimhan Nagan, Wilhelm W Just, et al.
Molecular Genetics and Metabolism|April 23, 2003
The frequency of short-chain acyl-CoA dehydrogenase gene variants in the US population and correlation with the C(4)-acylcarnitine concentration in newborn blood spotsNarasimhan Nagan, Kent E Kruckeberg, Angela L Tauscher, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Distinct rates of VUS reclassification are observed when subclassifying VUS by evidence levelGwendolyn Bennett, Izabela Karbassi, Wenjie Chen, et al.
Pageof 3